Real-world effectiveness and safety of lebrikizumab in adults with moderate-to-severe atopic dermatitis: a retrospective observational study with focus on head and neck involvement.

Ebglyss (lebrikizumab-lbkz) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42615070

Alfredo Belcastro; Claudia Paganini; Cosimo DI Raimondo; Edoardo Mortato; Lorenzo Tofani; Luca Bianchi; Marco Galluzzo; Marina Talamonti; Virginia Maffei

Aug 20, 2026